BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct acting antivirals
1
Generic vs brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children
12/26/2025 10:27:29 AM | Browse: 177 | Download: 686
2
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?
6/14/2024 8:01:41 AM | Browse: 174 | Download: 640
3
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
5/22/2024 11:33:24 AM | Browse: 441 | Download: 1112
4
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C
12/25/2023 6:03:15 AM | Browse: 370 | Download: 1920
5
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 456 | Download: 1511
6
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM | Browse: 738 | Download: 2260
7
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
6/23/2022 2:39:01 PM | Browse: 925 | Download: 2234
8
Breakthroughs and challenges in the management of pediatric viral hepatitis
5/20/2021 8:38:05 AM | Browse: 1038 | Download: 2103
9
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 1899 | Download: 2332
10
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 1773 | Download: 2270
11
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 1591 | Download: 3041
12
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
3/4/2018 12:36:47 PM | Browse: 1443 | Download: 2172
13
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1728 | Download: 3312
14
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
7/5/2017 4:40:08 AM | Browse: 1484 | Download: 2718
15
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
3/6/2017 3:54:00 PM | Browse: 1854 | Download: 2513
16
Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment
2/26/2017 6:20:00 PM | Browse: 1846 | Download: 2183
17
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
11/4/2016 10:35:00 AM | Browse: 1671 | Download: 3135
18
Hepatitis C virus: A time for decisions. Who should be treated and when?
1/29/2016 11:06:00 AM | Browse: 1613 | Download: 3132
19
Treatment strategies for chronic hepatitis C prior to and following liver transplantation
1/7/2016 12:14:00 PM | Browse: 1503 | Download: 2277
20
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM | Browse: 2464 | Download: 3191
21
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1985 | Download: 2620
22
Predictive factors associated with hepatitis C antiviral therapy response
6/29/2015 5:40:00 PM | Browse: 1560 | Download: 2697
23
Hepatitis C virus: Virology, diagnosis and treatment
6/3/2015 12:01:00 PM | Browse: 2050 | Download: 2727
24
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM | Browse: 1545 | Download: 2980
25
Impact of all oral anti-hepatitis C virus therapy: A meta-analysis
4/19/2015 5:46:00 PM | Browse: 1501 | Download: 2404
26
Management of patients with hepatitis C infection and renal disease
2/13/2015 9:30:00 AM | Browse: 1941 | Download: 1853
27
Complementary and alternative medications in hepatitis C infection
9/10/2014 6:38:00 PM | Browse: 1399 | Download: 1401
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.